Clinical application: Treatment in a mouse model with milciclib in combination with mirvetuximab significantly reduced tumor ...

Imagine a drug that halts cancer without side effects or risks. That future may be a bit nearer thanks to recent research led ...

Spatial proteo-transcriptomic profiling reveals the molecular landscape of borderline ovarian tumors and their invasive progression, Cancer Cell, June 2025 DOI: (25)00253-3 ...

"Being able to predict the response of cancer to treatment by analyzing a tumor sample before therapy is given would significantly impact clinical outcomes," said first author Dr. Eric Jaehnig ...

“The next step will be to assess whether targeting MLF2 and RBM15 can kill cancer cells or merely slow their growth. In the longer term, the goal is to identify the most effective molecules to correct ...

OncoHost, a technology company transforming the approach to precision medicine for improved patient outcomes, today announced ...

The hunt for a medical breakthrough has been caught up in the Trump administration's political assault on the university.

Indian American biomedical researcher has reported novel biomarkers for colorectal, bladder, prostate, stomach and pancreatic ...

More information: Zhaoxiang Cai et al, Federated deep learning enables cancer subtyping by proteomics, Cancer Discovery (2025). DOI: 10.1158/2159-8290.CD-24-1488 Journal information: Cancer Discovery ...

Envision this possible future clinical scenario: a breast cancer patient and her physicians are deciding on the best possible treatment. Their decision is informed by a comprehensive molecular ...